0001562180-17-002413.txt : 20170705 0001562180-17-002413.hdr.sgml : 20170705 20170705174620 ACCESSION NUMBER: 0001562180-17-002413 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170701 FILED AS OF DATE: 20170705 DATE AS OF CHANGE: 20170705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eansor Norman David CENTRAL INDEX KEY: 0001270905 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 17948671 MAIL ADDRESS: STREET 1: 8100 SOUTHPARK WAY, A-8 CITY: LITTLETON STATE: CO ZIP: 80120 FORMER NAME: FORMER CONFORMED NAME: EANSOR N DAVID DATE OF NAME CHANGE: 20031120 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2017-07-01 false 0000842023 BIO-TECHNE Corp TECH 0001270905 Eansor Norman David 8100 SOUTHPARK WAY, A-8 LITTLETON CO 80120 false true false false SVP - Novus Biologicals Common Stock 2017-07-01 4 F false 534.00 117.50 D 3402.00 D Restricted Stock Units Common Stock 1500.00 1500.00 D Restricted Stock Units Common Stock 2287.00 2287.00 D Stock Option (Right to Buy) 108.49 2022-08-07 Common Stock 12500.00 12500.00 D Stock Option (Right to Buy) 108.49 2022-08-07 Common Stock 9375.00 9375.00 D Stock Option (Right to Buy) 94.35 2021-08-12 Common Stock 15000.00 15000.00 D Stock Options (Right to buy) 106.59 2023-08-18 Common Stock 18819.00 18819.00 D Stock Options (Right to buy) 106.59 2023-08-18 Common Stock 14114.00 14114.00 D Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). 3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19. 3,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18. Vests 4,705 shares on 8/18/17, 8/18/18, and 8/18/19 and 4,704 shares on 8/18/20. /s/ Kathy Backes as Attorney-in-Fact for David N. Eansor pursuant to Power of Attorney previously filed. 2017-07-05